102 related articles for article (PubMed ID: 17487752)
1. Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma.
Berglund M; Thunberg U; Fridberg M; Wingren AG; Gullbo J; Leuchowius KJ; Amini RM; Lagercrantz S; Horvat A; Enblad G; Söderberg O
Leuk Lymphoma; 2007 May; 48(5):1038-41. PubMed ID: 17487752
[No Abstract] [Full Text] [Related]
2. T-cell/histiocyte-rich large B-cell lymphoma associated with a near-tetraploid karyotype and complex genetic abnormalities.
de Leval L; Harris NL; Lampertz S; Herens C
APMIS; 2006 Jun; 114(6):474-8. PubMed ID: 16856972
[TBL] [Abstract][Full Text] [Related]
3. A human B-cell lymphoma line with a de novo multidrug resistance phenotype.
Mohammad RM; Mohamed AN; KuKuruga M; Smith MR; al-Katib A
Cancer; 1992 Mar; 69(6):1468-74. PubMed ID: 1540884
[TBL] [Abstract][Full Text] [Related]
4. The molecular cytogenetic aberration analyzed by comparative genomic hybridization and its significance in diffuse large B-cell lymphoma.
Xia HL; Chen LJ; Chen B; Jin XL; Chen SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):12-5. PubMed ID: 16456777
[TBL] [Abstract][Full Text] [Related]
5. [Diffuse large cell B lymphoma: from morphology to biology].
Gaulard P
Ann Pathol; 2006 Nov; 26 Spec No 1():1S28-32. PubMed ID: 17149170
[No Abstract] [Full Text] [Related]
6. T(3;7)(q27;q32) fuses BCL6 to a non-coding region at FRA7H near miR-29.
Schneider B; Nagel S; Kaufmann M; Winkelmann S; Bode J; Drexler HG; MacLeod RA
Leukemia; 2008 Jun; 22(6):1262-6. PubMed ID: 17989715
[No Abstract] [Full Text] [Related]
7. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
Kubuschok B; Trepel M
Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
[TBL] [Abstract][Full Text] [Related]
8. U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.
Sambade C; Berglund M; Lagercrantz S; Sällström J; Reis RM; Enblad G; Glimelius B; Sundström C
Int J Cancer; 2006 Feb; 118(3):555-63. PubMed ID: 16106419
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib.
Shringarpure R; Catley L; Bhole D; Burger R; Podar K; Tai YT; Kessler B; Galardy P; Ploegh H; Tassone P; Hideshima T; Mitsiades C; Munshi NC; Chauhan D; Anderson KC
Br J Haematol; 2006 Jul; 134(2):145-56. PubMed ID: 16846475
[TBL] [Abstract][Full Text] [Related]
10. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
[TBL] [Abstract][Full Text] [Related]
11. Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.
Yonetani N; Akasaka T; Akasaka H; Ohno H; Okuma M; Miura I; Takahashi N; Miyanishi S; Okumura A; Muramatsu M; Fukuhara S
Oncogene; 1998 Aug; 17(8):971-9. PubMed ID: 9747876
[TBL] [Abstract][Full Text] [Related]
12. A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma.
Amini RM; Berglund M; Rosenquist R; Von Heideman A; Lagercrantz S; Thunberg U; Bergh J; Sundström C; Glimelius B; Enblad G
Leuk Lymphoma; 2002 Nov; 43(11):2179-89. PubMed ID: 12533045
[TBL] [Abstract][Full Text] [Related]
13. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
14. Primary marginal zone lymphoma of the thymus accompanied by chromosomal anomaly 46,X,dup(X)(p11p22).
Harigae H; Ichinohasama R; Miura I; Kameoka J; Meguro K; Miyamura K; Sasaki O; Ishikawa I; Takahashi S; Kaku M; Sasaki T
Cancer Genet Cytogenet; 2002 Mar; 133(2):142-7. PubMed ID: 11943341
[TBL] [Abstract][Full Text] [Related]
15. AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.
Tsai HJ; Shih NY; Kuo SH; Cheng AL; Lin HY; Chen TY; Chang KC; Lin SF; Chang JS; Chen LT
Leuk Lymphoma; 2015; 56(9):2674-82. PubMed ID: 25535814
[TBL] [Abstract][Full Text] [Related]
16. Numerical chromosomal abnormality in gastric MALT lymphoma and diffuse large B-cell lymphoma.
Watanobe I; Takamori S; Kojima K; Fukasawa M; Beppu T; Futagawa S; Hirai S
J Gastroenterol; 2002; 37(9):691-6. PubMed ID: 12375141
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous regression of malignant lymphoma of the breast.
Iihara K; Yamaguchi K; Nishimura Y; Iwasaki T; Suzuki K; Hirabayashi Y
Pathol Int; 2004 Jul; 54(7):537-42. PubMed ID: 15189510
[TBL] [Abstract][Full Text] [Related]
18. [Gene expression profiling of de novo CD5-positive diffuse large B-cell lymphoma].
Kobayashi T; Kim S; Zhang W; Yamaguchi M; Ueno S; Morikawa J; Shiku H
Rinsho Ketsueki; 2003 Mar; 44(3):144-8. PubMed ID: 12722340
[No Abstract] [Full Text] [Related]
19. Simian AIDS-related lymphoma growth in severe combined immunodeficiency mice is independent of karyotypic abnormalities or Bcl-6 mutations.
Castaños-Vélez E; Heiden T; Lindvall C; Capello D; Sandlund A; Imreh S; Blennow E; Andersson LC; Gaidano G; Nordenskjöld M; Biberfeld P
AIDS Res Hum Retroviruses; 2002 Mar; 18(5):383-90. PubMed ID: 11897040
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults.
Dave BJ; Weisenburger DD; Higgins CM; Pickering DL; Hess MM; Chan WC; Sanger WG
Cancer Genet Cytogenet; 2004 Sep; 153(2):115-21. PubMed ID: 15350300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
